Cannara Biotech Inc Financial Flexibility Index
Cannara Biotech Inc financial flexibility index. Cannara Biotech Inc (LOVE) has a Financial Flexibility Index of 0.20x as of November 2025. Free cash flow of CA$12.58 Million (operating CF CA$7.96 Million minus capex CA$4.62 Million) represents 0% of total liabilities (CA$62.63 Million). Explore Cannara Biotech Inc capex to cash flow ratio to see what proportion of operating cash flow is directed to capital expenditures.
Financial Flexibility Index
Free Cash Flow
Total Liabilities
Capital Expenditures
Financial Flexibility Index of Cannara Biotech Inc (2018–2025)
Financial flexibility index of Cannara Biotech Inc from 2018 to 2025. Historical Financial Flexibility Index trend for Cannara Biotech Inc across 8 annual periods. Check cash flow reinvestment rate of Cannara Biotech Inc to assess the company's total reinvestment commitment from operating cash flow.
Cannara Biotech Inc Financial Flexibility Index by Year (2018–2025)
Cannara Biotech Inc financial flexibility index by year from 2018 to 2025. Year-by-year free cash flow to debt coverage for Cannara Biotech Inc. For the full cash flow conversion analysis, see LOVE cash flow metrics.
| Year | Flexibility Index | Free Cash Flow (CAD) | Operating CF | Total Liabilities | YoY Change |
|---|---|---|---|---|---|
| 2025 | 0.40x | CA$26.37 Million | CA$20.01 Million | CA$66.43 Million | ▲ +46.0% |
| 2024 | 0.27x | CA$18.15 Million | CA$10.68 Million | CA$66.77 Million | ▲ +6.4% |
| 2023 | 0.26x | CA$15.79 Million | CA$5.91 Million | CA$61.78 Million | ▲ +66.9% |
| 2022 | 0.15x | CA$9.02 Million | CA$-6.08 Million | CA$58.88 Million | ▼ -85.0% |
| 2021 | 1.02x | CA$28.51 Million | CA$-2.09 Million | CA$27.91 Million | ▲ +11872.3% |
| 2020 | -0.01x | CA$-143.08K | CA$-9.32 Million | CA$16.49 Million | ▼ -101.0% |
| 2019 | 0.86x | CA$15.60 Million | CA$-7.41 Million | CA$18.17 Million | ▼ -52.7% |
| 2018 | 1.81x | CA$25.61 Million | CA$-2.30 Million | CA$14.12 Million | — |